Selected for OXB’s VectorXcellerator programme
Cure Lowe Foundation is among the first programmes selected for VectorXcellerator, run by OXB (Oxford Biomedica), a specialist manufacturer of gene therapies.
Through the programme our team works with OXB on manufacturing feasibility studies and gets support on the manufacturing and quality side of development.
Making a gene therapy at the quality and scale needed for patients is one of the hardest and most expensive parts of the road. Starting that work early, with an experienced partner, takes risk out of the steps that follow.
Thank you to the team at OXB for building a programme like this for rare disease innovators.
All stories